Revvity

RVTYPre-clinical

Waltham, United StatesFounded 2002revvity.com

Revvity, formerly PerkinElmer's life sciences business, is a leading provider of health science technologies and services focused on accelerating innovation across the drug discovery and development continuum. The company offers integrated workflow solutions including analytical instruments, imaging systems, software platforms, and laboratory services to support customers from target identification through clinical development. With a strong market position in life sciences tools and diagnostics, Revvity serves over 190 countries and maintains a diversified portfolio spanning research, applied, and diagnostics markets.

Market Cap

$9.6B

Founded

2002

Employees

8,000-12,000

Focus

Diagnostics

RVTY · Stock Price

USD 85.9490.86 (-51.39%)

Historical price data

AI Company Overview

Technology Platform

Integrated health science technology platform providing analytical instruments, imaging systems, laboratory automation, software solutions, and services for drug discovery, development, and diagnostics workflows.

Funding History

Total raised: $750M

Debt$750MUndisclosedMar 15, 2021

Opportunities

Significant growth opportunities from increasing life sciences R&D spending, expanding precision medicine initiatives, and growing demand for laboratory automation and advanced analytics in both developed and emerging markets.

Risk Factors

Key risks include intense competition from larger players like Thermo Fisher and Danaher, need for continuous R&D investment to maintain technology leadership, and potential customer spending volatility during economic downturns.

Competitive Landscape

Revvity competes in the large life sciences tools market against major players including Thermo Fisher Scientific, Agilent, and Danaher. The company differentiates through integrated workflow solutions and specialized expertise, though it faces challenges from competitors with broader portfolios and greater scale.

Publications

Patents